http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008528456-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008528456-A
titleOfInvention Novel pharmaceutical composition comprising candesartan cilexetil as lipophilic crystalline substance
abstract Novel candesartan cilexetil compositions are prepared with up to 20% of carrageenan that adequately stabilizes the active ingredient against degradation during tableting.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014088123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5844929-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013224265-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603804-B2
priorityDate 2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0546358-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001010825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002020319-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0006126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004131675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9737688-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449420124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16069996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451581117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407458795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457169682

Total number of triples: 64.